Protective effect of picolinic acid on mice intracerebrally infected with lethal doses of Candida albicans
- PMID: 7506894
- PMCID: PMC192402
- DOI: 10.1128/AAC.37.11.2422
Protective effect of picolinic acid on mice intracerebrally infected with lethal doses of Candida albicans
Abstract
We have studied the effects of picolinic acid (PLA), a product of tryptophan degradation, on mouse susceptibility to intracerebral infection with Candida albicans. We show that intraperitoneal administration of PLA significantly enhances the median survival time of mice inoculated with the lethal challenge. Furthermore, intracerebral administration of this agent induces a protective state against the local lethal infection, the phenomenon depending upon the administration schedule and doses of PLA employed. According to survival data, yeast growth in the brain as well as yeast colonization of the kidneys are drastically reduced in PLA-treated mice compared with those for untreated controls. Northern (RNA) blot analysis of brain tissues demonstrates that mRNA levels specific for tumor necrosis factor and interleukin 1 are augmented and induced, respectively, after inoculation of PLA. These results indicate that PLA has a protective effect likely involving elicitation of a cytokine response in vivo against fungal infections.
Similar articles
-
Pattern of cytokine gene expression in brains of mice protected by picolinic acid against lethal intracerebral infection with Candida albicans.J Neuroimmunol. 1994 Jul;52(2):205-13. doi: 10.1016/0165-5728(94)90114-7. J Neuroimmunol. 1994. PMID: 8034759
-
Intracerebral transfer of an in vitro established microglial cell line: local induction of a protective state against lethal challenge with Candida albicans.J Neuroimmunol. 1991 Jun;32(3):249-57. doi: 10.1016/0165-5728(91)90195-d. J Neuroimmunol. 1991. PMID: 2033118
-
Differential host susceptibility to intracerebral infections with Candida albicans and Cryptococcus neoformans.Infect Immun. 1993 Aug;61(8):3476-81. doi: 10.1128/iai.61.8.3476-3481.1993. Infect Immun. 1993. PMID: 8335378 Free PMC article.
-
Augmented inhibition of Candida albicans growth by murine neutrophils in the presence of a tryptophan metabolite, picolinic acid.J Infect Chemother. 2004 Jun;10(3):181-4. doi: 10.1007/s10156-004-0311-9. J Infect Chemother. 2004. PMID: 15290459
-
CpG oligodeoxynucleotides protect mice from lethal challenge with Candida albicans via a pathway involving tumor necrosis factor-alpha-dependent interleukin-12 induction.FEMS Immunol Med Microbiol. 2007 Oct;51(1):155-62. doi: 10.1111/j.1574-695X.2007.00292.x. FEMS Immunol Med Microbiol. 2007. PMID: 17854477
Cited by
-
Role of Kynurenine and Its Derivatives in the Neuroimmune System.Int J Mol Sci. 2024 Jun 28;25(13):7144. doi: 10.3390/ijms25137144. Int J Mol Sci. 2024. PMID: 39000249 Free PMC article. Review.
-
Metabolomics reveals differential levels of oral metabolites in HIV-infected patients: toward novel diagnostic targets.OMICS. 2013 Jan;17(1):5-15. doi: 10.1089/omi.2011.0035. Epub 2011 Jul 13. OMICS. 2013. PMID: 21751871 Free PMC article.
-
The kynurenine pathway and inflammation in amyotrophic lateral sclerosis.Neurotox Res. 2010 Aug;18(2):132-42. doi: 10.1007/s12640-009-9129-7. Epub 2009 Nov 18. Neurotox Res. 2010. PMID: 19921535
-
Kynurenine pathway metabolites in humans: disease and healthy States.Int J Tryptophan Res. 2009;2:1-19. doi: 10.4137/ijtr.s2097. Epub 2009 Jan 8. Int J Tryptophan Res. 2009. PMID: 22084578 Free PMC article.
-
Peripheral and central kynurenine pathway abnormalities in major depression.Brain Behav Immun. 2022 Mar;101:136-145. doi: 10.1016/j.bbi.2022.01.002. Epub 2022 Jan 6. Brain Behav Immun. 2022. PMID: 34999196 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical